News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Opthea.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Revenue, profit down at Opthea but investors don’t seem to mind
Health & Biotech
Opthea’s 100pc jump was great, but only scratched the surface, says CEO Megan Baldwin
Health & Biotech
Check-up: Opthea’s one-day gain has them leading the health pack
Health & Biotech
Health: Opthea’s anti-macular degeneration drug passes Phase IIb trial, shares double
Health & Biotech
Health: Get a load of this new brain scanner that Compumedics has installed
Director Trades
Director Trades: The people with the perfect timing
Health & Biotech
Standout pupils: These three eyecare stocks are schooling the healthcare small caps
Health & Biotech
Did you see this coming? Opthea eyes good ocular trial results
Health & Biotech
Cashed-up Opthea just got good news about its eye disease drug trials
Health & Biotech